专家文章 | 魏艳玲

搜索
登录

热心肠智库专家文章 | 魏艳玲

2023

CAEfficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design

Gut Microbes, 10.1080/19490976.2023.2284247

点击查看热心肠日报解读

CAThe role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease

FMICB, 10.3389/fmicb.2023.1188455

CADevelopment and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis

THER ADV GASTROENTER, 10.1177/17562848231170945

CAThe role of Th17 cells in inflammatory bowel disease and the research progress

Front Immunol, 10.3389/fimmu.2022.1055914

2022

CAPHF Technique: A Pyramid Hybrid Feature Fusion Framework for Severity Classification of Ulcerative Colitis Using Endoscopic Images

Bioengineering-Basel, 10.3390/bioengineering9110632

CAPHF3 Technique: A Pyramid Hybrid Feature Fusion Framework for Severity Classification of Ulcerative Colitis Using Endoscopic Images

Bioengineering-Basel, 10.3390/bioengineering9110632

CAPHF3 Technique: A Pyramid Hybrid Feature Fusion Framework for Severity Classification of Ulcerative Colitis Using Endoscopic Images

Bioengineering-Basel, 10.3390/bioengineering9110632

CAClinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules

FCIMB, 10.3389/fcimb.2022.1025889

CAGut microbiota: A new target for T2DM prevention and treatment

FRONT ENDOCRINOL, 10.3389/fendo.2022.958218

CARoseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Nutrients, 10.3390/nu14153041

CARoseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Nutrients, 10.3390/nu14153041

CARoseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Nutrients, 10.3390/nu14153041

CARoseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Nutrients, 10.3390/nu14153041

CARoseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Nutrients, 10.3390/nu14153041

CARoseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Nutrients, 10.3390/nu14153041

CADevelopment and Validation of a Deep Neural Network for Accurate Identification of Endoscopic Images From Patients With Ulcerative Colitis and Crohn's Disease

FRONT MED-LAUSANNE, 10.3389/fmed.2022.854677

CANeurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome

FRONT ENDOCRINOL, 10.3389/fendo.2022.817100

2021

CAFecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study

FCIMB, 10.3389/fcimb.2021.759435

点击查看热心肠日报解读

CARFWD3 Participates in the Occurrence and Development of Colorectal Cancer via E2F1 Transcriptional Regulation of BIRC5

Front Cell Dev Biol, 10.3389/fcell.2021.675356

CARFWD3 Participates in the Occurrence and Development of Colorectal Cancer via E2F1 Transcriptional Regulation of BIRC5

Front Cell Dev Biol, 10.3389/fcell.2021.675356